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Abstract
Background: The Goto-Kakizaki (GK) rat is a well-studied non-obese spontaneous type 2 diabetes (T2D) animal model
characterized by impaired glucose-stimulated insulin secretion (GSIS) in the pancreatic beta cells. MicroRNAs (miRNAs) are
short regulatory RNAs involved in many fundamental biological processes. We aim to identify miRNAs that are differentially-
expressed in the pancreatic islets of the GK rats and investigate both their short- and long term glucose-dependence during
glucose-stimulatory conditions.
Methodology/Principal Findings: Global profiling of 348 miRNAs in the islets of GK rats and Wistar controls (females, 60
days, N=6 for both sets) using locked nucleic acid (LNA)-based microarrays allowed for the clear separation of the two
groups. Significant analysis of microarrays (SAM) identified 30 differentially-expressed miRNAs, 24 of which are
predominantly upregulated in the GK rat islets. Monitoring of qPCR-validated miRNAs during GSIS experiments on isolated
islets showed disparate expression trajectories between GK and controls indicating distinct short- and long-term glucose
dependence. We specifically found expression of rno-miR-130a, rno-miR-132, rno-miR-212 and rno-miR-335 to be regulated
by hyperglycaemia. The putative targets of upregulated miRNAs in the GK, filtered with glucose-regulated mRNAs, were
found to be enriched for insulin-secretion genes known to be downregulated in T2D patients. Finally, the binding of rno-
miR-335 to a fragment of the 39UTR of one of known down-regulated exocytotic genes in GK islets, Stxbp1 was shown by
luciferase assay.
Conclusions/Significance: The perturbed miRNA network found in the GK rat islets is indicative of a system-wide
impairment in the regulation of genes important for the normal functions of pancreatic islets, particularly in processes
involving insulin secretion during glucose stimulatory conditions. Our findings suggest that the reduced insulin secretion
observed in the GK rat may be partly due to upregulated miRNA expression leading to decreased production of key proteins
of the insulin exocytotic machinery.
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Introduction
MicroRNAs (miRNAs) are ,21-23 nucleotides (nt) long, non-
coding RNAs which negatively regulate expression of genes via
mRNA degradation, mRNA deadenylation and/or translational
repression [1]. However, during the cell cycle arrest some miRNAs
may mediate translational activation of specific transcripts [2]. A
single miRNA may have multiple target genes and it is estimated
that 20% of all mammalian genes may be direct targets for post-
transcriptional silencing [3]. Thus one miRNA is capable of
causing widespread changes in the proteins synthesis for thousands
of genes [4]. MiRNAs have been shown to be involved in various
aspects of fundamental cellular and physiological processes such as
in cell differentiation, proliferation, apoptosis, morphogenesis, fat
metabolism, hormone secretion, and long-term memory [5].
Hence deregulated miRNA expression has been implicated in
many diseases, particularly in many different types of human
cancer [6,7], in cardiovascular and skeletal muscle diseases [8] and
in neurodegenerative diseases such as Alzheimer’s disease [9] and
amyotrophic lateral sclerosis (ALS) [10].
The link between miRNA and diabetes began with the
discovery of a highly-expressed pancreatic islet miRNA, miR-
375. It was then shown to be involved in exocytosis via the
targeting of the myotrophin gene in a still unclear mechanism
[11]. Recently it was shown that miR-375 knockout mice display
elevated plasma glucose levels due to a small reduction in beta cell
mass with a concomitant increase in the number of alpha cells per
islet as well as increased circulating glucagon [12]. Currently, a
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functioning of the insulin-secreting beta cell, albeit mostly in
cultured cell lines [13].
The Goto-Kakizaki (GK) rat, selectively bred from Wistar rats
with high blood glucose levels, is a well-studied non-obese
spontaneous type 2 diabetes animal model [14]. Its main associated
diabetic phenotype regardless of colony source is impaired glucose-
stimulated insulin secretion (GSIS)[15,16].Indeedgenetic lesionsin
the GK rat point to defects in vital components of the canonical
secretion coupling of the pancreatic islet beta cell. In particular,
reduced expression of a number of exocytotic soluble N-ethylma-
leimide-sensitive factor attachment protein receptor (SNARE)
complex proteins has been shown in GK rat islets [17,18], similar
to those observed in type 2 diabetic humans [19].
The contribution of miRNAs to the development of diabetes in
the GK rat has been largely unexplored. Insulin resistance in
target tissues is one aspect of the GK diabetic phenotype and
miRNA profiling studies on skeletal muscle, liver and adipose
tissues of the diseased animal have been performed [20,21].
However, there has been no systematic study on the GK
pancreatic islet miRNAs. Here we investigated the miRNA
expression profiles in the pancreatic islets of the GK rat compared
to the Wistar controls and evaluated both the short term and long
term glucose-dependence of differentially-expressed miRNAs.
Results
Phenotype of GK/MolTac versus aged-matched Wistar
rats
Consistent with previous studies on 8-week old Stockholm
colony GK rats [22] as well as in GK/MolTac subline [23], we
observed significantly elevated non-fasting blood glucose levels in
our rats (10.260.5 mM, N=10) compared to the age-matched
Wistar controls (6.760.4 mM, N=10) (p=7.5610
25) (Fig. 1A).
The plasma insulin levels displayed non-significant differences
between the two groups of animals (Fig. 1B), though there is a
tendency for the GK rats at this age to exhibit elevated circulating
insulin consistent with hyperglycaemia and impending diabetic
state as the animals get older [23].
Another well-known phenotype of GK rat is insulin resistance in
target tissues. In the aforementioned study of Ostenson and co-
workers, results of intra-peritoneal glucose tolerance test showed
rapid increase in blood glucose to a maximum 20 mmol/L (vs
8 mmol/L in Wistar control). After 120 minutes, the blood glucose
in the GK was still twice its fasting level clearly indicating an
impaired insulin response [22].
A hallmark feature of diabetic GK rats regardless of sub-line is
impaired GSIS whether in in vivo studies, perfused pancreas or in
freshly isolated islets (reviewed in [16]). Indeed, in agreement with
other studies on isolated GK islets, we observed reduced insulin
response in islets stimulated in 8.3 mM and 16.7 mM glucose,
80% and 60% lower levels respectively, than the Wistar islets
(N=3,p,0.001) (Fig. 1C).
Global miRNA profiling of pancreatic islets of GK rats and
Wistar controls
Hierarchical clustering of the global miRNA profiles comprising
348 rat miRNAs allowed clear separation of the GK rats from the
controls (Fig. 2A). Significant analysis of microarrays (SAM)
identified 30 differentially-regulated miRNAs, 24 of which are
predominantly upregulated in the GK rat islets (Fig. 2B) (median
False Discovery Rate, FDR=0%). Employing SAM without large
fold-change threshold requirement allowed for the identification of
differentially-regulated miRNAs with small but consistent differ-
ences among the individual animals from each group.
Using miRNA-specific stem-loop qPCR assays [24] we
validated the expression of ten most upregulated miRNAs from
the significant list, and also prioritizing miRNAs which appeared
in previous studies on pancreatic islets or insulin-secreting beta cell
lines such as miR-124, miR-376a, miR-132 and miR-212. We also
included the most consistently down-regulated miRNA, rno-miR-
708, in the GK rat islets for validation. As a negative control we
included rno-miR-375, being found not to be differentially-
regulated in the arrays (Figure S1B). In agreement with the array
results, we observed significant upregulation in the qPCR of the
selected miRNAs in the GK rat islets compared to the controls
(p,0.05; Fig. 2C).
Glucose regulation of differentially-expressed miRNAs in
Wistar and GK islets
Since one of the major diabetic phenotypes of GK rats is
impaired GSIS, we investigated whether the differentially-
Figure 1. Phenotype of the GK rats at the time of islets collection. A. Non-fasting intra-cardial blood glucose levels are elevated in the GK rats
compared to non-diabetic Wistar controls (N=10 in both groups). B. Plasma insulin levels are at comparable levels between the two groups of
animals (N=8 in both groups). C. Insulin secretion is reduced in the isolated pancreatic islets of GK rat at 8.3 mM and 16.7 mM glucose (N=3
independent RIA in quadruplicate per assay). Data are average 6 SEM; (***) P,0.001 GK vs Wistar.
doi:10.1371/journal.pone.0018613.g001
Glucose-Regulated MicroRNAs in GK Rat Islets
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both in the short-term (1 h) and long-term (24 h) exposure to
varying glucose concentrations. The three glucose concentrations
used were 2.8 mM (2.8G), 8.3 mM (8.3G) and 16.7 mM (16.7G),
representing hypoglycaemic, near-physiological and hyperglycae-
mic environments.
In the 1 h incubation (Fig. 3), with the exception of rno-miR-
142-3p and rno-miR-335, the relative expression levels of the
miRNAs at 2.8G were similar to those of freshly isolated islets
(Fig. 3; p,0.05 vs 2.8G in Wistar), i.e. GK miRNAs significantly-
upregulated in the microarrays consistently exhibited higher levels
of expression than the Wistar miRNAs, whereas rno-miR-708
which was found to be downregulated in GK was minimally
expressed. Among the miRNAs tested only rno-miR-130a, rno-
miR-132, rno-miR-212 and rno-miR-335 responded to glucose
stimulation at either 8.3 mM or 16.7 mM in the healthy Wistar
islets (Fig. 3; p,0.05).
In GK, more pronounced variation of miRNA expression
trajectories (magnitude and direction of expression) were observed
upon glucose stimulation at 8.3G, especially for rno-miR-124, rno-
miR-142-5p and rno-miR-409-3p (Fig. 3; p,0.01 vs 2.8G in GK).
In fact, a number of miRNAs are markedly decreased at 8.3G. In
virtually all upregulated miRNAs in the GK, their levels at 16.7G
are significantly greater than the levels found in Wistar. Even rno-
miR-375 which was non-responsive at stimulatory conditions in
Wistar significantly increased in GK at 16.7G (Fig. 3; p,0.05).
For islets incubated 24 h in 2.8 mM glucose, the expression
levels of the miRNAs in the GK also reflected the results found in
the miRNA arrays of freshly isolated islets, except for rno-142-3p
and rno-142-5p (Fig. 4). Nonetheless the latter two still showed a
tendency to be at higher levels in the GK than in the Wistar. In
general, aside from more significant changes in expression levels of
miRNAs at 24 h incubation compared to 1 h incubation, three
trends in terms of expression changes are also observed in the
Wistar islet upon stimulation at 16.7G as compared to 2.8G: i)
increasing miRNA levels, as displayed by rno-miR-132, rno-miR-
212 and rno-miR-409-3p, ii) decreasing miRNA levels as exhibited
by rno-miR-124, rno-miR-142-3p, rno-miR-375, rno-miR-335,
rno-miR-130a and rno-miR-708, and iii) no significant change as
displayed by rno-miR-376a, rno-miR-142-5p and rno-miR-433.
In comparison, the expression trajectories of some miRNAs in
the GK islets also follow similar trends as in the Wistar islets, such
as rno-miR-124, rno-miR-142-3p and rno-miR-375. In contrast,
rno-miR-212 and rno-miR-132 showed the opposite trend leading
to decreased miRNA levels upon stimulation at 16.7 G. Thus, for
miRNAs that increases with increasing glucose concentrations in
the normal Wistar islets, the GK islet miRNAs levels go down
(rno-miR-132 and rno-miR-212) or do not change (rno-miR-409-
3p), whereas for miRNAs whose levels decrease with increasing
glucose concentration in Wistar islets, the GK islet miRNAs is also
reduced (e.g. rno-miR-124, rno-miR-142-3p, rno-miR-375) (Fig. 4).
These results indicate compensatory mechanisms in the GK
islets striving to reset the levels of miRNAs to that of the controls
during prolonged exposure to hyperglycaemic condition. This is
clearly seen for rno-miR-212, rno-miR-132, and rno-miR-130a,
whose expression levels in the GK and Wistar islets eventually
coincide at 16.7G (Fig. 4). However, despite these attempts in the
GK islet to attain normal levels of miRNAs, failures were seen in
most GK miRNAs wherein the levels at 16.7G either overshoot
those of Wistar’s as in rno-miR-142-3p, rno-miR-142-5p, rno-
miR-375 and rno-miR-124, or completely miss the normal levels
as in the case of rno-miR-335 and rno-miR-376a (Fig. 4).
Gene ontology enrichment of the putative targets of co-
regulated miRNAs
Next we were interested to find potential targets proteins of
miRNAs up-regulated in the GK rat. The poor overlap between
different miRNA target prediction algorithms is well known and
the lack of rationale behind filtering of targets by using multiple
target prediction algorithms has been demonstrated [25]. Since
spatio-temporal co-expression of mRNA and miRNAs is more
important in assessing reliability and accuracy of target
predictions than conservation scores [26], we chose to exclusively
use TargetScan Release 5.1 (April 2009) [27] to retrieve all
putative targets, both highly-conserved and rat-specific miRNA
targets. Target Scan predicted a total of 13591 target genes for
the ten co-expressed miRNAs upregulated in the GK rat (data
not shown).
To reduce the amount of false positive hits, the predicted targets
were then filtered by intersecting with a list of glucose-regulated
mRNAs expressed in isolated rat islets incubated in low, medium
and high glucose levels [28] (Fig. 5). This resulted to 1342 glucose-
regulated target genes in the rat pancreatic islets (Table S1). Gene
ontology enrichment aiming for the biological process category
revealed functional clusters significantly enriched for genes
involved in transport and secretory processes (Table 1). The
functional annotation clustering is based on the idea that similar
gene members would be expected to fall into similar annotation
groups. Indeed the annotations between the two clusters are highly
related with a combined 125 genes among the different gene
ontologies. Of these genes, ,50% (60/125) have more than one
miRNA predicted target sites (Table S2). Table 2 shows
representative target genes known to be involved in insulin
exocytosis potentially regulated by miRNAs.
Targeting of rat Stxbp1-39UTR by rno-miR-335
Stxbp1 (Syntaxin-binding protein 1) or Munc18-1 plays an
important role in the fusion of insulin secretory granules in the
plasma membrane of the beta cell by modulating the folded
conformation of syntaxin 1A [29]. Not surprisingly, the expression
level of Stxbp1 is reduced in the islets of both T2D patients [19]
and GK rats [18]. The proximal region of the rat Stxbp1 39UTR
contains two miR-335 binding sites as predicted by TargetScan
(Fig. 6A). Two dual luciferase reporter constructs, one with
wildtype and another with mutant sequence in the miR-335
binding site seed regions were constructed. The inserts are
,200 nt long encompassing the two miR-335 binding site of the
Figure 2. Global miRNA profiles of the pancreatic islets of GK and Wistar rats and qPCR validation. A. Hierarchical clustering of array
signals from 348 rat miRNAs allowed for the separation of the individual animals into two groups, 6 GK vs 6 Wistar. Rat miR-375, miR-132 and miR-708
are indicated for reference, representing no significant change (dark tones), upregulated (yellow tones) and downregulated (blue tones) miRNAs in
GK. B. Significant Analysis of Microarrays (SAM) identified 30 differentially-regulated miRNAs in the GK rat pancreatic islets, clustered into 6
downregulated and 24 upregulated miRNAs (median False Discovery Rate = 0%). C. Stem-loop qPCR validation of selected 12 miRNAs in GK and
Wistar islets. Mir-375 was included as a non-regulated control. Each miRNA was normalized to the geometric mean of U6 snRNA and U87 rat
expressions as implemented in GeNorm v3.5. The 2
-DDCt method was used for relative quantification using the Wistar expression level as calibrator.
The presented data are the average of N=3 biological replicates performed independently each in triplicate qPCR wells 6 SEM; (*) P,0.05, (**)
P,0.01, (***) P,0.001 GK vs Wistar.
doi:10.1371/journal.pone.0018613.g002
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variation of miRNA expression trajectories (magnitude and direction of expression) were observed in the GK compared to Wistar islets across the
different glucose concentrations. Each miRNA was normalized to the geometric mean of U6 snRNA and U87 rat. The 2
-DDCt method was used for
relative quantification using Wistar expression level at 2.8G as calibrator. The presented data are the average of N=3 biological replicates performed
independently each in triplicate qPCR wells 6 SEM. Intra-sample (within same animal group) significance denoted by (*) P,0.05, (**) P,0.01, (***)
P,0.001 vs 2.8G of same animal group. Inter-sample (W vs GK) significance denoted by ({) P,0.05, ({{) P,0.01, ({{{) P,0.001, compares expression
levels from different animal groups of the same incubating glucose concentration. Different y-axis scaling was used for each miRNA to allow easy
comparison of expression levels across different conditions.
doi:10.1371/journal.pone.0018613.g003
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plasmid containing wildtype seed sequence into HeLa cells showed
a ,30% reduction in the luciferase signal (Fig. 6B) indicating a
binding interaction between the miRNA and the target sites. This
interaction is lost when the plasmid construct with mutations in the
seed sequence of miR-335 binding site was used instead (Fig. 6B).
These results were consistent and were also observed in the
insulin-secreting cell line, INS1-832/13 (data not shown).
Altogether, these results suggest the direct targeting of rat Stxbp1
by rno-miR-335.
Figure 4. Glucose-dependence of miRNA levels after 24 h incubation at 2.8 mM, 8.3 mM and 16.7 mM glucose. Three general trends of
miRNA expression trajectories were observed for Wistar islets at 2.8G vs 16.7G: i) increased expression as exhibited by rno-miR-132, rno-miR-212 and
rno-miR-409-3p, ii) decreased expression as in the case of rno-miR-124, rno-miR-142-3p, rno-miR-375, rno-miR-335, rno-miR-130a and rno-miR-708
and, iii) no change as seen in rno-miR-376a, rno-miR-142-5p and rno-miR-433. For GK islet expression, the miRNAs generally exhibited expression
trajectories aimed at attaining Wistar islet levels. Data analysis and presentation are as described for Figure 3.
doi:10.1371/journal.pone.0018613.g004
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We have shown differential miRNA expression profiles in the
isolated pancreatic islets of mildly hyperglycaemic GK rats
compared to that of healthy Wistar controls. One of the strengths
of this work lies in the use of LNA-based arrays. In such arrays, the
capture oligonucleotide probes were adjusted within a narrow
melting temperature range by introducing LNA monomers
yielding optimal hybridisation conditions. Recently, the utility
and reliability of these arrays were shown to be comparable, if not
superior to next generation high-throughput sequencing ap-
proaches to expression profiling [30]. Thus, in combination with
profiling of as many as six individual biological replicates from
each phenotypic group, our array results validated by qPCR
experiments undoubtedly identified genuine miRNA expression
differences in the pancreatic islets of the two sets of animals.
Four of the glucose-regulated miRNAs found in this study, mir-
124, mir-212, mir-132, and mir-409-3p, were previously reported
to be upregulated in the mouse insulin secreting cell line, MIN6,
after 16 h stimulation in 25 mM glucose [31], which is noteworthy
despite that tumour-derived cell lines have been shown to
generally exhibit significantly different miRNA signature com-
pared to primary cells [6].
Interestingly, miR-212 and miR-132 have also been shown to
be upregulated in isolated pancreatic islets in the obese phenotypes
of both the diabetes-resistant (B6) and diabetes-susceptible (BTBR)
mouse models [32]. The deregulated expression of mir-132 and
mir-212 in different experimental models strongly links these
miRNAs to common pathways underlying the disease pathologies
of diabetic GK rats and obese mouse models.
We found that incubation of isolated rat islets in different
glucose concentrations and lengths of time revealed differences in
both magnitude and direction of miRNA expression between the
model animals and the controls. We saw changes in miRNA
expression manifested within a short temporal window of only one
hour, such as for rno-miR-130a, rno-miR-132, rno-miR-212 and
rno-miR-335. These miRNAs are most likely regulated by
hyperglycaemia rather than the GK phenotype per se since they
responded to glucose stimulation even in the Wistar islets.
A further evidence of active regulation of miRNAs during short-
term fluctuation of glucose levels is the prominent decrease of
some miRNAs at 8.3G, which is a clear deviation from the typical
up or down glucose concentration-dependent mode of regulation.
Interestingly, this was also reported in the work of Bensellam and
co-workers in which more than 400 mRNA probe-sets displayed
atypical expression patterns, e.g. V- or inverse-V- shaped across
four glucose concentrations. Furthermore, statistically-significant
changes in gene expression were predominantly observed between
G5 and G10 indicating active gene regulation mechanisms aimed
at keeping optimal islet function during physiological glucose levels
[28]. In our 1 h incubation time, we also observed more significant
changes in miRNA expression from 2.8G to 8.3G in both the
Wistar and GK islets. However, the phenomenon of markedly
decreased miRNA levels at 8.3 G was more seen in the GK islets
than in the controls indicating greater requirement in the diseased
Figure 5. In silico strategy to analyze the miRNAs upregulated
in the GK rat islets. One of the highlights of the approach is the
filtering of predicted targets with known glucose-regulated mRNA data
set from a previous study, significantly reducing false positive targets.
This also resulted to a more focused enrichment of genes already
implicated in islet functions.
doi:10.1371/journal.pone.0018613.g005
Table 1. Gene ontology enrichment of the putative gene targets of ten upregulated GK islet miRNAs.
Functional Group 1
Gene ontology (GO) term Gene count Fold Enrichment P-value Bonferroni corrected
GO:0015031,protein transport 87 2.1 2.78E-11 6.86E-08
GO:0046907,intracellular transport 96 2.0 8.04E-11 1.98E-07
GO:0006886,intracellular protein transport 63 2.2 8.18E-09 2.02E-05
Functional Group 2
Gene ontology (GO) term Gene count Fold Enrichment P-value Bonferroni corrected
GO:0045045,secretory pathway 44 2.3 3.55E-07 8.76E-04
GO:0006888,ER to Golgi vesicle-mediated transport 17 4.4 5.46E-07 1.35E-03
GO:0048193,Golgi vesicle transport 22 3.2 3.49E-06 8.58E-03
GO:0032940,secretion by cell 46 2.0 5.27E-06 1.29E-02
1342 glucose-regulated putative gene targets (listed in Table S1) of ten upregulated miRNAs in GK rat islets yielded two statistically-significant clustering of Gene
Ontology (GO) terms characterising transport and secretory processes.
doi:10.1371/journal.pone.0018613.t001
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molecules.
Rapid modulation of cellular miRNAs was previously observed
in human hepatoma cell line and primary murine hepatocytes
where IFNb treatment lead to induction of specific miRNAs
within just 30 minutes of incubation [33]. In another study the
presence of discrete populations of miRNAs in specific regions of
the human brain with half-lives in the order of minutes-to-hours
suggested the presence of a rapidly deployed miRNA-dependent
signalling system in central nervous system gene expression [34].
In the case of pancreatic islet cells, we speculate that the glucose-
regulated miRNAs could be envisioned as vital components of a
rapid physiological response mechanism activated during nutrient-
induced insulin secretion. Indeed, among the filtered predicted
targets of the upregulated miRNAs in the GK rats in particular
rno-miR-335, are enriched for several key exocytotic proteins
(Table 2), some of which were shown to have reduced expression
in human T2D cases including Stxbp1 (Munc18-1) whose 39UTR
fragment we have shown to interact with miR-335.
Islets incubated for 24 h at 2.8G and 16.7G represent exposure
to chronic states of hypo- and hyperglycaemia, respectively. Such
extended exposure of islets to non-physiological glucose environ-
ments is more aimed at studying the effects of nutrient availability
and in the case of higher glucose concentrations, also imposes
effects of gluco-toxicity on islet function. A longer incubation time
also allows for the observation of constitutively regulated miRNAs.
Figure 6. Interaction of rno-miR-335 with the predicted binding sites in the 39UTR of rat Stxbp1. A. The rat Stxbp1 39UTR contains two
putative miR-335 binding sites as predicted by TargetScan 5.1. The two sites are located in the proximal region and both could be included in a
200 bp fragment cloned into a dual luciferase reporter plasmid. Arrows indicate the sites in the seed sequences that were mutated into
complementary bases to act as negative control in the luciferase assay B. Two inserts, one with the wildtype rat Stxbp1-39UTR sequence (Wt) and the
other with sequences mutated at both miR-335 predicted binding sites (Mut) were cloned into the pmiRGLO dual luciferase vector. The pmiRGLO
dual luciferase vector alone (Empty) was included as positive controls. HeLa cells were co-transfected with the empty vector or plasmid constructs
and pre-miR-335 or pre-miR-scr (control with scrambled sequence) and assayed after 48 hours. Transfection efficiency was normalized using the
Renilla signal. Data represents two independent transfections 6 S.E.M. with n=3. (**) P,0.01.
doi:10.1371/journal.pone.0018613.g006
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compensatory mechanisms attempting to bring the expression
levels of specific miRNAs within the islets of the GK animals
towards that of the controls. This trend was particularly distinct for
both miR-212 and miR-132, which belong to the same gene
cluster being only 200 nt apart and containing identical seed
sequences. Additionally, the genes encoding both miRNAs
harbour a cAMP-response element binding protein (CREB) site
indicating common regulation by the same transcription factor
[35]. The observed deregulation of these miRNAs in the GK islets
during GSIS may not necessarily be a negative consequence of the
disease phenotype but could also be a way to reset the relevant
proteins to wild-type levels.
The presence of deregulated miRNAs in the GK rat islet is
strikingly clear, but how do miRNAs ultimately contribute to the
islet’s specialized function as a hormone-secreting factory? In a
recent review, D.P. Bartel (2009) outlined different scenarios of
miRNA-mediated regulatory effects, wherein miRNAs may act as
binary off switches, rheostats or as facilitators of neutral interactions
[26]. The pancreatic islets are source of hormones with opposing
effects and are subjected to constantly fluctuating signals. It is rather
intuitive that such a complex system would require fine tuning
mechanisms to ensure optimal levels of regulatory proteins at any
given time. Thus, miRNA as rheostat capable of regulating gene
expression for optimal protein output [36] would be a likely
component of such fine tuning interaction for the proper functioning
of pancreatic islets. Disruption of this balancing mechanism
ultimately leads to impaired cellular processes triggering abnormal
physiological manifestations as seen in many human diseases.
It is well-known that the lower capacity of GK islets to secrete
insulin under glucose stimulatory conditions is not due to reduced
stores of islet hormones since insulin content in GK islets and
controls are comparable [22]. These results are compatible with
the idea that one of the primary causes of the diabetic phenotype
in GK rats lies in a defective exocytotic machinery in the islets
[16]. In fact careful electrophysiological measurements on GK rat
beta cells strongly indicate that the events downstream of glucose
metabolism in the canonical GSIS mechanism are defective [37].
As in the case of type 2 diabetic humans, the GK rat diabetic
phenotype is also characterized by downregulation of key
exocytotic proteins in the pancreatic beta cell [15]. Specifically,
deficiencies in the SNARE complex proteins have been shown to
impair insulin secretion [17]. Altogether, previous knowledge
about the GK phenotype supports our computationally-predicted
list of target genes enriched for genes involved in transport and
secretion processes, containing genes known to play central roles in
insulin exocytosis (Table 2). This is further strengthened by our
experimental validation of rno-miR-335 interaction with Stxbp1
39UTR (Fig. 6).
To conclude, we hypothesize that the imbalance in the miRNA
network in the GK rat islets may contribute to the impaired GSIS
characteristic of the animals, though it cannot be excluded that
such perturbation may serve as a resetting/compensatory
mechanism to counteract the disease phenotype. It should also
be noted that the in vitro experiments performed on isolated
pancreatic islets may only partially reflect the dynamic nature of
miRNA regulation happening in vivo. Nonetheless, the potential
role of miRNAs in regulating the insulin exocytotic machinery will
pave further investigation about the contribution of deregulated
miRNAs in T2D. Translating these findings into the context of
human T2D and further characterization of other hypothesized
miRNA-target interactions would certainly contribute to under-
standing the roles of these relatively novel regulatory molecules in
the aetiology of the disease.
Materials and Methods
Ethics Statement
All animal experimentations were approved by the local ethics
committee of Lund University under permit number M 185 06
and M 73 08.
Experimental animals, monitoring of glycaemia and
plasma insulin
Female GK/MolTac and control Wistar rats, 60 days old, were
purchased from Taconic Europe. The GK inbred model was
Table 2. Representative target genes from the enriched GO categories known to be involved in insulin exocytosis.
Entrez ID Gene Name Gene Symbol Comment miRNA
25012 Synaptosomal-associated protein 25SNAP25 t-SNARE protein rno-miR-409-3p, rno-miR-335
64630 Synaptosomal-associated protein 23SNAP23 t-SNARE protein rno-miR-124
81802 Syntaxin 3 STX3 t-SNARE protein rno-miR-142-5p, rno-miR-132
80843 Sec 61, alpha subunit (S. cerevisiae) SEC61A1 role in the insertion of secretory and membrane polypeptides into
ER
rno-miR-130a, rno-miR-212
25558 Syntaxin binding protein 1 STXBP1 Munc18-1; SNARE accesory factor rno-miR-433, rno-miR-335
60355 N-Ethylmaleimide sensitive fusion
protein
NSF involved in the disruption of the SNARE-complex after fusion rno-miR-142-3p, rno-miR-132,
rno-miR-376a
140594 Synaptotagmin-like 4 SYTL4 granuphilin/Slp-4; important in docking of insulin-containing
granules
rno-miR-132
116657 Complexin-2 CPLX2 possible minor role in insulin exocytosis; 80% similar to CPLX1
involved in GSIS
rno-miR-335
56768 Piccolo PCLO complexes with Epac2; involved in cAMP-dependent exocytosis rno-miR-142-5p, rno-miR-433,
rno-miR-142-3p
64088 Sorting nexin 16 SNX16 effects on EGF receptor trafficking rno-miR-142-5p, rno-miR-132,
rno-miR-142-3p, rno-miR-409-
3p
Table S2 contains the full list of enriched target genes and putative regulating miRNAs.
doi:10.1371/journal.pone.0018613.t002
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MolTac rats develop T2D at around 14–16 weeks of age (http://
www.taconic.com). Non-fasting glucose levels were measured from
intra-cardiac blood using a glucose meter (ACCU-CHEK Aviva,
Roche) immediately after killing. Plasma insulin was measured by
RIA. Due to insufficient amount of islets from individual animals,
separate batches of animals were used for in vitro insulin-secretion
assay and global profiling of miRNA expression.
Islet preparation and in vitro insulin-secretion assay
Pancreatic islets were isolated by collagenase digestion and the
islets were handpicked in cold Hank’s buffer with 1 mg/mL
bovine serum albumin (BSA) prior to secretion assays. Islets from
three individual animals (no pooling) were seeded in separate wells
in plates containing Krebs buffer with 2.8 mM glucose. After 1 h
pre-incubation at 37uC with 5% CO2, the islets were transferred in
new plates with fresh medium at desired glucose concentrations
and incubation time. In parallel, batches of 10–12 intact islets were
transferred into new tubes in quadruplicates for 1 h or 24 h GSIS.
Samples were retrieved from the tubes for insulin secretion assays
using RIA. The islets from plates were collected and processed
immediately for total RNA preparation and stem loop qPCR.
Global LNA-based miRNA expression profiling and data
analysis
Total RNA from freshly isolated islets from individual animals
was extracted using the Qiagen miRNeasy isolation kit (Qiagen,
Hilden, Germany). The quality of the total RNA was evaluated
both by spectrophotometry and electropherogram profiles using
Nanodrop and Experion’s automated electrophoresis system (Bio-
Rad). All samples have Abs 260/280 ,2.0, Abs 260/230 .1.4
and Experion’s RNA Quality Indicator (RQI) .7.0, indicating
high-quality total RNA preparations and consistent extraction
procedure (data not shown). A reference pool was made from
mixing equal amount of total RNA from the individual animals.
500 ng of total RNA from each sample and reference pool were
labelled with miRCURY
TM Hy3
TM and Hy5
TM fluorescent label
(Exiqon, Denmark). The Hy3
TM-labeled samples and a Hy5
TM-
labeled reference pool RNA samples were mixed pair-wise and
hybridized to the miRCURY
TM LNA array v.11.0 (Exiqon,
Denmark) according to manufacturer’s protocol for Maui
hybridisation chamber. The LNA array contains capture probes
targeting 348 rat miRNAs listed in the miRBASE version 12.0
release [38]. Images were acquired using an Agilent array scanner
and spot signals were processed (default background subtraction)
and quantified using GenePix Pro 4.1. Intensities within arrays
were normalized using the global Lowess (LOcally WEighted
Scatterplot Smoothing) regression algorithm as implemented in
the Comprehensive R-based Microarray Analysis web front end
(CARMAweb 1.4) [39]. The log2 values of the difference between
the sample and reference signals were used for hierarchical
clustering using Cluster 3.0 [40] and the values were visualized
with Java TreeView 1.0.12 [41].
miRNA-specific stem-loop qPCR
Total RNA from all islet samples were prepared and quality
checked as above. MiRNA expression was measured by stem-loop
qPCR using primers and probes from TaqMan MicroRNA assays
(Applied Biosystems). For each experimental condition, three
separate real-time PCR runs were performed from islet prepara-
tions from different individuals (N=3), each in triplicate wells in
384-well plates using Applied Biosystems 7900HT RT-PCR
system.
U6 snRNA and U87 rat showed stable expression levels in all
conditions tested in the two groups of animals (Figure S2) and both
were used as endogenous controls. The method described in
GeNorm [42] was used to derive normalization factors from the
multiple internal control genes and relative quantification was
performed using the 2
2DDCt method. Wistar expression levels were
used as calibrators in qPCR on fresh islets, while Wistar expression
level at 2.8 mM glucose were used as calibrators in qPCR on
GSIS experiments.
In-silico prediction and functional analysis of miRNA
targets
TargetScan Release 5.1 (April 2009) [27] was used to retrieve all
putative targets, both highly-conserved and rat-specific miRNA
targets. The predicted targets were then intersected with a list of
glucose-regulated mRNAs expressed in rat islets, supplementary
material of Bensellam et al (2009) [28], which were re-annotated
with the latest available Affymetrix annotation file, Rat230_
2.na30.annot.csv (Release 30, 11/15/2009). Gene ontology
enrichment on the final gene list (Table S1) was performed using
DAVID 2008 tools as described [43]. Figure 5 summarizes the
analysis strategy.
Plasmid construction and dual luciferase assay
To generate the inserts encompassing the two rno-miR-335
binding sites in the proximal region of Stxbp1-39UTR, single-
stranded oligonucleotide sequences (ultramers
TM) were pur-
chased (Integrated DNA Technologies, Inc. Germany). The
sequences included position 1368 to 1547 (TargetScan numbering)
of the 39UTR of Stxbp1 (NM_003165). To facilitate directional
insertion into the pmiRGLO dual luciferase miRNA target
expression vector (Promega, USA; Cat#E1330), PmeI and NotI
restriction sites were also added in the 59end and XbaI site in the
39end (underlined italics). The sequences of the 195 nt strands are:
i) sense strand: 59-AAACTAGCGGCCGCCTTCTTTTGTCC-
CTTCTCTCTGGTCAAGCAATGCTCTTGCTTCAGGACC-
TTGTTTGTCGAACATGTGGGGTTTCCTTTATGTTATT-
TATATAAATAATTTCTCAAATGGATATTTAAAAAAAAAG-
CTAGTCTGTCTTGAAACTTGTTAACTTGAAACTCTTGA-
ATCTCAGTGTTTAAAGTT and ii) antisense strand: 59-CTAGA-
ACTTTAAACACTGAGATTCAAGAGTTTCAAGTTAACA-
AGTTTCAAGACAGACTAGCTTTTTTTTTAAATATCCA-
TTTGAGAAATTATTTATATAAATAACATAAAGGAAAC-
CCCACATGTTCGACAAACAAGGTCCTGAAGCAAGAG-
CATTGCTTGACCAGAGAGAAGGGACAAAAGAAGGCG-
GCCGCTAGTTT. These strands were allowed to form a duplex
prior to ligation within the multiple cloning site downstream of the
luc2 reporter gene in the linearized vector. This resulted to the
dual-luciferase reporter containing wildtype rno-miR-335 binding
seed sequences (bold sequences). Another pair of ultramers
containing mutations (bold-underlined mutated into complemen-
tary bases) in the two rno-miR-335 seed sequence binding sites is
likewise inserted into a separate pmiRGLO vector resulting to the
mutant construct. Sequences and orientation of inserts in both
constructs were verified by sequencing (GATC Biotech, Ger-
many).
A day before transfection, ,6000 HeLa cells were seeded in 96-
well plate containing MEM (Invitrogen; Cat#10370) supplement-
ed with 2 mM L-glutamine, 1 mM sodium pyruvate, 10% heat
inactivated fetal bovine serum (Sigma #7524), 100 U/ml
penicillin and 100 mg/ml streptomycin (Sigma # P0781) while
,30000 INS1-832/13 cells were seeded in 96-well plate
containing RPMI 1640 (Gibco Cat #21875) with 11.1 mM D-
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serum (Sigma #7524), 100 U/ml penicillin and 100 mg/ml
streptomycin (Sigma # P0781), 10 mM HEPES (Sigma
#H0887), 2 mM L-glutamine (Sigma #G7513), 1 mM sodium
pyruvate (Sigma #S8636) and 50 mM ß-mercaptoethanol, cul-
tured at 37uC and 5% CO2 in a humidified atmosphere. The
empty vector and plasmid constructs were then co-transfected with
either pre-miR-335 or pre-miR-scrambled negative control #1
(Applied Biosystems Europe BV) to 60–70% confluent HeLa or
INS1-832/13 cells using the Attractene transfection reagent
(Qiagen GmBh, Germany; Cat.# 1051561). Transfection exper-
iments were done independently for both cell lines two times in
triplicate wells.
The Firefly luciferase activity was measured 2 days post-
transfection using the Dual-Glo Luciferase assay system (Promega,
USA; Cat.#E2920). Both cell lines exhibited ,90% confluence by
the time of assay. Transfection efficiency was normalized using the
Renilla signal. Luminescence was acquired using the Magellan
software on Tecan Infinite M200 plate reader.
Statistical analysis
Insulin secretion, luciferase assays and qPCR data are presented
as mean 6 SEM and p values are from two-tailed Student’s t test.
Values of p,0.05 were considered as statistically significant. For
LNA arrays, Significant Analysis of Microarrays (SAM) was
performed as implemented in MeV v4.3 for two class unpaired
without using the fold-change criterion [44]. Briefly, SAM two
class unpaired is similar to a between subjects t tests wherein mean
expressions in two groups are adjudged significant based on the
calculated statistic, d, from the original and permuted data for each
gene. The observed vs expected d values may be adjusted using a
Delta parameter allowing for identification of significant genes even
with small but consistent differences. SAM also estimates the False
Discovery Rate (FDR) giving the proportion of significant genes
most likely identified by chance. In this study, we set the Delta
parameter to a conservative level corresponding to median
FDR=0%, i.e. the median number of false positives calculated
during the procedure is equal to zero.
Supporting Information
Figure S1 Relative abundance of selected miRNAs in the
pancreatic rat islet. A. Quantile plots of miRNA signals from
LNA (locked nucleic acid) arrays of total RNA of Wistar and GK
pancreatic islets. The Hy3 fluorescence (sample signals) of
miRNAs from six arrays of independent biological replicates from
each animal group were averaged. B. Significant Analysis of
Microarray (SAM) was performed on Hy3/Hy5 ratios (sample
signal to reference signal ratio). Significant hits identified by SAM
have fold-changes of at least 1.5.
(PDF)
Figure S2 Evaluation of stability of endogenous controls
for qPCR and array signals of the selected miRNAs. A.
Distribution of the average raw Ct values of each miRNA in the 14
qPCR conditions. B. Quantile plots of the average raw Ct values
showing median expression levels and scatter of data points.
(PDF)
Table S1 List of 1342 rat genes which are intersection of
glucose-responsive genes (Bensellam et al 2009) and collective
miRNA targets in this study.
(XLS)
Table S2 List of 125 rat genes which are enriched for Transport
and Secretory Processes with their corresponding putative miRNA
regulator.
(XLS)
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